| 4:00–8:00 PM | Registration | 3rd Floor Foyer |
| 6:00–8:00 PM | Welcome Mixer | 3rd Floor Foyer |
| 7:00–8:00 AM | Breakfast | Summit Gallery |
| 8:00–9:00 AM | Welcome and Keynote Address (Joint) | Breckenridge Ballroom |
| Alexandra Trkola, University of Zürich HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure |
| 9:00–11:15 AM | Immune Interventions Interfacing HIV Prevention and Cure (Joint) | Breckenridge Ballroom |
| Mauricio A. Martins, University of Florida Promoting Persistent bNAb Expression in NHPs through AAV-Mediated Gene Transfer |
| Devi SenGupta, Gilead Sciences, Inc. Long-acting ART in HIV Prevention and Cure |
| Leonidas Stamatatos, Fred Hutchinson Cancer Research Center Vaccination of PLWH, using 426C Derived Immunogens |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break | 1st Floor Foyer |
| 9:50–9:55 AM | Award Recipient Acknowledgement | Breckenridge Ballroom |
| 11:15–1:00 PM | Poster Setup | Peaks 1 - 3 |
| 11:15–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing | Peaks 1 - 3 |
| 2:30–4:30 PM | Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions | Colorado Ballroom |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available | 3rd Floor Foyer |
| 5:00–7:00 PM | Keeping up with the Changing HIV Envelope | Colorado Ballroom |
| Penny L Moore, University of the Witwatersrand and National Institute for Communicable Diseases African bNAb Immunogens |
| Margaret E. Ackerman, Dartmouth College Fc Effector Function in HIV Infection and Vaccination |
| Aime Marcel Simon Tongo Passo, Center for Research on Emerging and Re-Emerging Diseases (CREMER/IMPM) Viral Diversity in Central Africa: Known and Unknowns |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner | Summit Gallery |
| 7:30–10:00 PM | Poster Session 1 | Peaks 1 - 3 |
| 7:00–8:00 AM | Breakfast | Summit Gallery |
| 8:00–11:00 AM | The Vaccine Pipeline: Integrating Basic and Clinical Insights | Colorado Ballroom |
| Speaker to be Announced |
| Richard T. Wyatt, The Scripps Research Institute Triggering bNAbs in Non-Human Primates |
| Persephone Borrow, University of Oxford Creating an Immune Environment Favorable for HIV-1 bnAb Induction |
| Louis J. Picker, Oregon Health & Science University Progress in CMV based Vaccines |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break | 3rd Floor Foyer |
| 11:00–1:00 PM | Poster Setup | Peaks 1 - 3 |
| 11:00–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing | Peaks 1 - 3 |
| 1:30–2:45 PM | Panel: Perspectives: Personalized Medicine & Patient-Centered Strategies (Joint) | Breckenridge Ballroom |
| 3:00–4:30 PM | Career Roundtable (Joint) | Breckenridge Ballroom |
| 4:30–5:00 PM | Coffee Available | 3rd Floor Foyer |
| 5:00–7:00 PM | Targeting the Needle in the Haystack: Clinical Trials of Germline Targeting Immunogens | Colorado Ballroom |
| Kevin O. Saunders, Duke University Induction of HCDR3-Binding and CD4 Mimicking Antibodies in HVTN300 and HVTN309 |
| Eunice Wambui Nduati, KEMRI, Wellcome Trust Germline Targeting Immunogens and Precursors in African Populations |
| Marit van Gils, Amsterdam UMC Germline Targeting Immunogens in Human Clinical Trials; C101, C107, C110 |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner | Summit Gallery |
| 7:30–10:00 PM | Poster Session 2 | Peaks 1 - 3 |
| 7:00–8:00 AM | Breakfast | Summit Gallery |
| 8:00–11:00 AM | Looking to the Future: New Tools, Platforms and Delivery Systems | Colorado Ballroom |
| Eric A. Appel, Stanford University Injectable Hydrogel Depot Technologies for Sustained Delivery of Vaccines |
| Shannon Miller, Inimmune Corporation Adjuvants for Mucosal Immunity |
| Speaker to be Announced |
| Rory Henderson, Duke University Large Language Models to Identify bnAbs and Design Vaccines to Them |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break | 3rd Floor Foyer |
| 11:00–5:00 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions | Colorado Ballroom |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available | 1st Floor Foyer |
| 5:00–6:45 PM | B Cell Responses and Broadly-Neutralizing Antibodies: Trials and Tribulations (Joint) | Breckenridge Ballroom |
| Marina F. Caskey, Rockefeller University Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies |
| Paula M. Cannon, University of Southern California, Keck School of Medicine Engineering B Cells as in vivo bnAb Factories |
| William Schief, The Scripps Research and IAVI Combining Germline Targeting Approaches Across Diverse bNAb Epitopes |
| Short Talk(s) Chosen from Abstracts |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) | Breckenridge Ballroom |
| 7:00–8:00 PM | Social Hour with Dinner | Summit Gallery |
| 8:00–9:00 PM | Cash Bar | Peaks 1 - 3 |
| 8:00–9:00 PM | Entertainment |
| 12:00–11:59 PM | Departure |